Copyright
©The Author(s) 2019.
World J Gastroenterol. Apr 14, 2019; 25(14): 1684-1696
Published online Apr 14, 2019. doi: 10.3748/wjg.v25.i14.1684
Published online Apr 14, 2019. doi: 10.3748/wjg.v25.i14.1684
Figure 3 Kaplan–Meier survival analysis of the gastric neuroendocrine carcinomas patients.
A: Patients with high infiltration of CD8+ lymphocytes tended to have a relative longer survival, but the difference was not statistically significant; B: Kaplan-Meier overall survival curves in patients with high and low expression of programmed death ligand 1 (PD-L1) in the whole population; C: Low PD-1+ cell infiltration group; D: High PD-1+ cell infiltration group. PD-L1: Programmed death ligand 1.
- Citation: Yang MW, Fu XL, Jiang YS, Chen XJ, Tao LY, Yang JY, Huo YM, Liu W, Zhang JF, Liu PF, Liu Q, Hua R, Zhang ZG, Sun YW, Liu DJ. Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas. World J Gastroenterol 2019; 25(14): 1684-1696
- URL: https://www.wjgnet.com/1007-9327/full/v25/i14/1684.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i14.1684